Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
13.21 (USD) • At close March 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| -80.941 | -29.725 | 9.349 | -203.674 | -72.148 | -25.991 | -21.785 | -10.902 | -24.603 | -19.449 | -32.834 | -10.548 | -1.579 | -3.929 |
| Depreciation & Amortization
| 3.544 | 2.957 | 1.527 | 1.193 | 0.882 | 0.684 | 0.582 | 0.41 | 0.061 | 0.051 | 0.031 | 0.008 | 0.007 | 0.006 |
| Deferred Income Tax
| 0 | 0 | 0 | -1.092 | 0.263 | 0.025 | 0.302 | 0 | 0 | -2.365 | -4.089 | 0.001 | 0 | 0 |
| Stock Based Compensation
| 37.988 | 34.649 | 30.611 | 28.915 | 6.764 | 1.982 | 1.259 | 2.17 | 2.5 | 2.365 | 4.089 | 1.54 | 0.026 | 1.553 |
| Change In Working Capital
| -20.809 | 7.381 | -12.557 | 31.233 | 21.216 | 15.982 | -1.156 | 7.364 | 2.678 | -1.115 | 0.388 | 1.443 | -0.101 | 0.009 |
| Accounts Receivables
| 28.09 | -29.3 | 0.603 | -1.242 | 0.054 | 2.302 | -4.001 | 3.153 | -1.556 | -1.077 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0.45 | 9.309 | 1.555 | 2.108 | -0.306 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | -2.238 | -3.112 | -0.769 | 4.812 | 3.155 | 0.578 | -1.537 | 0.471 | -0.248 | 0.258 | 0.024 | -0.113 | 0.095 |
| Other Working Capital
| -48.899 | 38.919 | -10.048 | 32.794 | 7.041 | 8.97 | 0.159 | 6.054 | 2.207 | -0.867 | 0.13 | 1.419 | 0.012 | -0.086 |
| Other Non Cash Items
| 0.471 | -33.361 | 3.063 | 8.382 | 0.162 | 0.873 | 0.038 | 0.498 | 0.123 | 2.365 | 4.089 | 0.203 | 0.062 | 0 |
| Operating Cash Flow
| -59.747 | -18.099 | 31.993 | -135.043 | -42.861 | -6.445 | -20.76 | -0.46 | -19.241 | -18.148 | -28.326 | -7.353 | -1.585 | -2.361 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| 0 | -2.901 | -7.726 | -3.406 | -1.742 | -0.818 | -1.478 | -0.251 | -0.074 | -0.181 | -0.079 | -0.039 | 0 | -0.024 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.029 | -20.022 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | -6.594 | 0 | -17.372 | -33.5 | 0 | -28.008 | 0 | -0.517 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 30.206 | 10.577 | 22.327 | 0 | 8.486 | 0 | 0.519 | 0 |
| Other Investing Activites
| -0.648 | 0 | -8.299 | -3.459 | -1.742 | -1.058 | 23.612 | 0.029 | 20.022 | -0.161 | 8.486 | -28.008 | 0.507 | -0.5 |
| Investing Cash Flow
| -0.648 | -2.901 | -7.726 | -3.406 | -1.742 | -0.818 | 22.134 | 10.355 | 4.881 | -33.842 | 8.407 | -28.047 | 1.026 | -1.041 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| 0 | -27.364 | -5 | 46.599 | 0 | 4.945 | 9.872 | 5.65 | 0 | 1.885 | 0 | 0.115 | 0.6 | 0.45 |
| Common Stock Issued
| 0.682 | 0.609 | 0.411 | 0.515 | 423.819 | 21.278 | 0.332 | 0.477 | 0 | 66.459 | 0 | 57.254 | 0.001 | 2.17 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 4.736 | 2.668 | 1.73 | 0.902 | 12.326 | 15.684 | 0.332 | 1.348 | 0.006 | -66.442 | 0 | 0.029 | 0 | 0 |
| Financing Cash Flow
| 5.418 | -24.087 | -2.859 | 48.016 | 436.145 | 41.907 | 10.204 | 6.998 | 0.006 | 66.472 | 0 | 57.398 | 0.601 | 2.62 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -54.977 | -45.087 | 21.408 | -90.433 | 391.542 | 34.644 | 11.578 | 16.893 | -14.354 | 14.482 | -19.919 | 21.998 | 0.042 | -0.782 |
| Cash At End Of Period
| 293.913 | 348.89 | 393.977 | 372.569 | 463.002 | 71.46 | 36.816 | 25.238 | 2.304 | 16.658 | 2.176 | 22.095 | 0.097 | 0.055 |